Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection
Keywords: هپاتیت سی; HCV; hepatitis C virus; CHC; chronic HCV; HCC; hepatocellular cancer; SVR; sustained virologic response; TRIM; tripartite motif; pegIFN-α/RBV; pegylated interferon-α and ribavirin; DDAs; direct-acting antivirals; RVR; rapid virologic response; cEVR; com